• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. INTERCEED* (TC7) ABSORBABLE ADHESION BARRIER; BARRIER, ABSORBABLE, ADHESION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. INTERCEED* (TC7) ABSORBABLE ADHESION BARRIER; BARRIER, ABSORBABLE, ADHESION Back to Search Results
Catalog Number 4350
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problems Adhesion(s) (1695); Fever (1858); Inflammation (1932); Irritation (1941); Pain (1994); Reaction (2414); Numbness (2415); No Code Available (3191)
Event Date 08/16/2016
Event Type  Injury  
Manufacturer Narrative
(b)(4).Inflammatory reaction occurred.The actual device batch number associated with this event is not known.The international affiliate reports the following possible batch numbers: batch# kbb2252, batch# kcb2541, batch# kcb3271, batch# kdb3642, batch# kdb3643, batch# kdb3901.In addition, a review of the batch manufacturing records for the possible batch numbers was conducted and the batches met all finished goods release criteria.To date the device has not been returned.If the device or further details are received at a later date, a supplemental medwatch will be sent.Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date, a supplemental medwatch will be sent.The patient demographic info: weight and bmi at the time of index procedure.What is the actual product lot number of the specific device used during the event? what is physician¿s opinion as to the etiology of or contributing factors to this event? has any medical intervention been provided for the ovarian and peritoneal irritation symptoms? what is the patient¿s current status?.
 
Event Description
It was reported that the patient underwent a laparoscopic oophorocystectomy procedure on (b)(6) 2016 and absorbable adhesion barrier was applied on the posterior surface of the uterus or on the entire left ovary.After the procedure, abdominal pain started and persisted.Then, on (b)(6) 2016, the patient experienced inflammatory reaction in the peritoneal cavity with fever in addition to ongoing abdominal pain.On (b)(6) 2016 the re-operation was performed and absorbable adhesion barrier had already become gelatinized.Since it was very difficult to remove absorbable adhesion barrier from the patient, intraperitoneal irrigation was also done.After the reoperation, inflammatory reaction and fever were subsided.However, ovarian and peritoneal irritation symptoms have been persisted since the reoperation.Because the patient has not been tolerated to any po intake since the reoperation, she is currently hospitalized.It was also reported that the ascitic fluid electrolytes level was unremarkable and the culture of post-operative drained exudate showed no sign of infection.The doctor opined that one of the contributing factors to this event might be due to absorbable adhesion barrier.Additional information has been requested.
 
Manufacturer Narrative
It was reported that it has been a month and a week since the device was used in the index procedure.Since the patient still has dull pain in the posterior uterus and the left ovary, she is not tolerated with po intake.Additional collection of blood sample was done and its result was unremarkable.On (b)(6) 2016, the open reoperation was done for the adhesion check, intraperitoneal irrigation, and direct palpation of the ovary.Although a corticosteroid injection had been given before this reoperation, there was no improvement of her symptoms.While the patient received daily po intake, her weight became less than 40 kg.Even though parenteral nutrition was given to her, it had to be stopped because she reported numbness in her body.During the reoperation, adhesion was confirmed by the surgeon.The patient has not been tolerated with po intake since the reoperation.The cause of abdominal dull pain (ovarian and uterine pain) is still unknown.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Type of Device
BARRIER, ABSORBABLE, ADHESION
Manufacturer (Section D)
ETHICON INC.
p.o. box 151, route 22 west
somerville NJ 08876 0151
Manufacturer (Section G)
ETHICON INC.-SAN LORENZO PR
982 road 183 km 8.3
san lorenzo PR 00754
Manufacturer Contact
kenneth clark
route 22 westp o box 151
somerville, NJ 08876
9082183547
MDR Report Key5978147
MDR Text Key55668363
Report Number2210968-2016-13885
Device Sequence Number1
Product Code MCN
Combination Product (y/n)N
PMA/PMN Number
P880047
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 09/07/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/26/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number4350
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Date Manufacturer Received09/29/2016
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age17 YR
-
-